OCULAR THERAPEUTIX INC (OCUL) Institutional Ownership Changes & 13F Activity

OCULAR THERAPEUTIX INC (OCUL) institutional ownership data tracks hedge funds, asset managers, and other institutional investors based on recent SEC 13F filings (Q1 2026). This page analyzes institutional buying and selling activity, new holdings, and sold-out positions among tracked filers. Notable filers include Renaissance Technologies LLC.

Portfolio quarterNameTypeQuantityRemainingReported stock balance
Q1 2026Renaissance Technologies LLCBuy356,7821,147,982$9,723,408
Q4 2025Renaissance Technologies LLCBuy381,152791,200$9,605,168
Q2 2025Renaissance Technologies LLCSell-43,952410,048$3,805,245
Q1 2025Renaissance Technologies LLCBuy424,300454,000$3,327,820
Q1 2024Renaissance Technologies LLCSell-95,50029,700$270
Q3 2023Renaissance Technologies LLCBuy100,307125,200$393
Q2 2023Renaissance Technologies LLCSell-46,30024,893$128
Q1 2023Renaissance Technologies LLCSell-222,80071,193$375
Q4 2022Renaissance Technologies LLCBuy279,200293,993$826
Q3 2022Renaissance Technologies LLCSell-366,70714,793$61
Q2 2022Renaissance Technologies LLCSell-129,305381,500$1,534
Q1 2022Renaissance Technologies LLCBuy430,705510,805$2,528
Q4 2021Renaissance Technologies LLCSell-166,10080,100$558
Q3 2021Renaissance Technologies LLCSell-80,922246,200$2,462
Q2 2021Renaissance Technologies LLCBuy277,222327,122$4,639
Q1 2021Renaissance Technologies LLCSell-284,16649,900$819
Q4 2020Renaissance Technologies LLCBuy245,166334,066$6,915
Q1 2017Renaissance Technologies LLCSell-56,20088,900$825
Q4 2016Renaissance Technologies LLCBuy97,800145,100$1,214
Q2 2016Renaissance Technologies LLCBuy36,30847,300$234
Q2 2015Renaissance Technologies LLCBuy10,99210,992$231

Frequently asked questions about OCUL activity

  • Which institutional owners are buying OCUL?

    Institutional owners buying OCUL include investors who have either initiated new positions or increased their existing holdings based on recent SEC 13F filings. The activity table above highlights which funds added shares in the latest reporting periods and how their positions changed over time.

  • What does "buy" mean in OCUL activity?

    "Buy" means an investor increased their reported position in OCUL compared to the prior reporting period. This reflects growing exposure to OCULAR THERAPEUTIX INC (OCUL) rather than necessarily a brand-new position (though new positions also appear as buys when prior quantity was zero).

  • Is institutional interest in OCUL increasing?

    Institutional interest in OCUL can be assessed by comparing the number of tracked funds adding or increasing positions versus those trimming or exiting across the periods shown. A higher number of additions typically signals increasing participation among large filers, but it should be read alongside position sizes and the full table.

Related OCUL insights